| PHAT Stock | | | USD 8.97 0.12 1.32% |
Phathom Pharmaceuticals financial indicator trend analysis is much more than just breaking down Phathom Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phathom Pharmaceuticals is a good investment. Please check the relationship between Phathom Pharmaceuticals Total Other Income Expense Net and its Cost Of Revenue accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phathom Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For more information on how to buy Phathom Stock please use our
How to Invest in Phathom Pharmaceuticals guide.
Total Other Income Expense Net vs Cost Of Revenue
Total Other Income Expense Net vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Phathom Pharmaceuticals Total Other Income Expense Net account and
Cost Of Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Phathom Pharmaceuticals' Total Other Income Expense Net and Cost Of Revenue is -0.02. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Phathom Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Phathom Pharmaceuticals' Total Other Income Expense Net and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Phathom Pharmaceuticals are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Total Other Income Expense Net i.e., Phathom Pharmaceuticals' Total Other Income Expense Net and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.02 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Total Other Income Expense Net
Cost Of Revenue
Cost of Revenue is found on Phathom Pharmaceuticals income statement and represents the costs associated with goods and services Phathom Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Phathom Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phathom Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phathom Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
For more information on how to buy Phathom Stock please use our
How to Invest in Phathom Pharmaceuticals guide.
Selling General Administrative is likely to gain to about 123.8
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 84.4
M in 2024.
Phathom Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Phathom Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phathom Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to
measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.